In conclusion, our study shows that i.m. vaccination against SARS-CoV-2 induces a transient mucosal immunity, which is characterized by IgG and therefore distinct from the mucosal immunity after infection, which is largely mediated by IgA. The gene discussed is CD79A; the disease is infection.